Xilio Therapeutics CEO René Russo's 2023 pay jumps 36% to $3M
Xilio Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 25, 2024
Xilio Therapeutics reported fiscal year 2023 executive compensation information on April 25, 2024.
In 2023, four executives at Xilio Therapeutics received on average a compensation package of $1.7M, a 20% increase compared to previous year.
Average pay of disclosed executives at Xilio Therapeutics
René Russo, Chief Executive Officer, received $3M in total, which increased by 36% compared to 2022. 71% of Russo's compensation, or $2.1M, was in option awards. Russo also received $263K in non-equity incentive plan, $598K in salary, as well as $14K in other compensation.
Christopher Frankenfield, Chief Operating Officer, received a compensation package of $1.9M. 62% of the compensation package, or $1.2M, was in option awards.
Martin Huber, Former President and Head of R&D, earned $1M in 2023, a 24% decrease compared to previous year.
Katarina Luptakova, Chief Medical Officer, received $932K in 2023.
Related executives
You may also like
Source: SEC filing on April 25, 2024.